knowledge -WSS

knowledge

author：fashion 2025-09-07 06:44:44 - browse：3558

UnitedHealth's CEO Andrew Witty stares into the camera at a hearing with his fingers locked — politics coverage from STAT — Kent Nishimura/Getty Images

On Wednesday, UnitedHealth CEO Andrew Witty appeared before Congress to answer for what lawmakers called a “single attack [that] kicked off a cascading series of crises that are unmasking some deep vulnerabilities in the core of our health care system”: the February Change Healthcare cyberattack that is still disrupting payment processing across the country.

Senators repeatedly interrupted Witty, trying to keep him to concrete answers and promises. Lawmakers on both sides of the aisle were exasperated with UnitedHealth. At one point, Sen. Thom Tillis (R-N.C.) held up a fifth-edition copy of “Hacking for Dummies” during the hearing.

“This is some basic stuff that was missed,” he said, referring to the fact that the hackers gained access to a Change server that didn’t have multi-factor authentication, a big problem for a company whose business is digital data. “So shame on internal audit, external audit and your system folks, those tasked with redundancy, they’re not doing their job. And as a result, we have a data breach.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Eli Lilly’s Mounjaro succeeds in second weight

explore

WSS

Bispecific antibodies are next new thing in cancer immunotherapy

Altering the blood type of lungs raises potential for universal organs for transplants

FDA proposes changes to key medical devices approval pathway

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Living organ donors deserve priority status for transplants

Biogen nominates mother of director’s child to replace him on board

hotspot

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Wikipedia

How one medical school became remarkably diverse

Will the IRA bring competition to the biologics market?

State Dept. review finds Biden bears some blame for Afghanistan failures

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Dobbs anniversary: the lost opportunity of abortion as health care

Biogen nominates mother of director’s child to replace him on board

The high cost of giving birth even with insurance

Sea level rise could wash away turtle breeding grounds around the world, researchers say

DIEP, the 'gold standard' of breast reconstruction, is under threat

How housing is health care on Long Island

entertainment

Xenotransplantation trials will require adjusting expectations, experts say

Bispecific antibodies are next new thing in cancer immunotherapy

A public health expert passes on football's full body collisions for youths

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Food makers to regulators: Ultra

Long Covid needs a new name — and a new frame

hotspot

hotspot

explore

hotspot